Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Formyl peptide receptor 3 (FPR3) is a G protein-coupled receptor (GPCR) involved in immune cell chemotaxis and inflammation. It functions as a low-affinity decoy receptor, primarily modulating immune signaling pathways by internalizing ligands and reducing their availability for other formyl peptide receptors. While its precise physiological role remains unclear, research suggests involvement in cellular metabolism and T cell migration during immune responses. It is characterized by rapid phosphorylation and internalization upon ligand binding, distinguishing it from other family members.
GPCR signaling modulation, primarily via internalization and decoy receptor function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Formyl peptide receptor 3 (FPR3).